Brooklyn Investment Group Purchases 830 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Brooklyn Investment Group grew its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 21.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,757 shares of the pharmacy operator’s stock after purchasing an additional 830 shares during the period. Brooklyn Investment Group’s holdings in Walgreens Boots Alliance were worth $44,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. State Street Corp boosted its stake in Walgreens Boots Alliance by 18.0% in the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after buying an additional 6,569,223 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Walgreens Boots Alliance by 43.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock valued at $98,284,000 after purchasing an additional 3,329,857 shares during the last quarter. Two Sigma Advisers LP purchased a new position in Walgreens Boots Alliance in the 3rd quarter worth $24,226,000. Thompson Siegel & Walmsley LLC lifted its stake in Walgreens Boots Alliance by 15.5% in the third quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock worth $62,325,000 after purchasing an additional 934,754 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Walgreens Boots Alliance by 12.1% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock valued at $68,046,000 after buying an additional 817,762 shares during the period. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on WBA shares. Royal Bank of Canada boosted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Evercore ISI boosted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. TD Cowen cut their target price on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, October 22nd. Morgan Stanley lowered their price target on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a report on Friday, October 11th. Finally, Truist Financial raised their price target on shares of Walgreens Boots Alliance from $10.00 to $13.00 and gave the stock a “hold” rating in a report on Thursday. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $13.27.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $12.52 on Monday. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $23.76. The company has a 50-day simple moving average of $9.57 and a two-hundred day simple moving average of $9.84. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. The firm has a market capitalization of $10.81 billion, a PE ratio of -1.22, a price-to-earnings-growth ratio of 1.55 and a beta of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The firm’s revenue was up 7.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.66 earnings per share. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.52 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were given a dividend of $0.25 per share. The ex-dividend date was Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a yield of 7.99%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently -9.77%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.